SB 894 — Drug Control Act; adds certain chemicals to Schedule I of Act.

R Acetyldihydrocodeine;

Cyprenorphine;e;Codeine-N-Oxide;

Cyprenorphine;

Morphine methylbromide;

Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation, which contains any quantity of the following hallucinogenic substances, or which contains any of its salts, isomers, and salts of isomers, whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation (for purposes of this subdivision only, the term "isomer" includes the optical, position, and geometric isomers):

Bufotenine;ltryptamineAlpha-methyltryptamine (other name:

Bufotenine;

of 10 Dimethyltryptamine;

of 9 Mescaline;

of 10 4-Iodo-2,5-dimethoxyphenethylamine (other name:

E 4-Ethylmethcathinone (other name:

N Beta-keto-methylbenzodioxolylpentanamine (other names:

R Alpha-methylamino-butyrophenone (other name:

Alpha-methylamino-valerophenone (other name:

Pentedrone);

3,4-dmmc);edrone);3,4-dmmc);

O 4-methyl-alpha-pyrrolidinopropiophenone (other name:

L 4-Iodo-2,5-dimethoxy-N-[(2-methoxyphenyl)methyl]-benzeneethanamine (other names:

Lof 9 Methoxetamine (other names:

E 4-Fluoromethamphetamine (other name:

D 2-(2,5-Dimethoxy-4-methylphenyl)ethanamine (other name:

2-[4-(Ethylthio)-2,5-dimethoxyphenyl]ethanamine (other name:

2C-T-2);

S (2-aminopropyl)benzofuran (other name:

8 (2-aminopropyl)-2,3-dihydrobenzofuran (other name:

4 4-chloro-2,5-dimethoxy-N-[(2-methoxyphenyl)methyl]-benzeneethanamine (other names:

R 2C-C-NBOMe, 25C-NBOMe, 25C);

Acetoxydimethyltryptamine (other names:

AcO-Psilocin, AcO-DMT, Psilacetin);

AcO-Psilocin, AcO-DMT, Psilacetin);

Beta-keto-N,N-dimethylbenzodioxolylbutanamine (other names:

Dibutylone, bk-DMBDB);

bk-2C-B);ne,bk-2C-B); bk-DMBDB);

1-(1,3-benzodioxol-5-yl)-2-(dimethylamino)-1-pentan(other1-(1,3-benzodioxol-5-yl)-2-(dimethylamino)-1-pentanone (other names:

N,N-Dimethylpentylone, Dip1-(4-methoxyphenyl)-2-(pyrrolidin-1-yl)octan-1-oneDipentylone); (other name:

1-(4-methoxyphenyl)-2-(pyrrolidin-1-yl)octan-1-one (other name:

5-methoxy-N,N-dimethyltryptamine (other name:

5-MeO-DMT);

of 10 6-allyl-6-nor-lysergic acid diethylamide (other name:

of 9 4-hydroxy-N,N-methylisopropyltryptamine (other name:

of 10 Clonazolam;

E Etizolam;

N Flubromazepam;

R Flubromazolam;

Gamma hydroxybutyric acid (some other names include GHB;

gamma hydroxybutyrate;

sodium oxybutyrate);te;oxybutyrate);

O Mecloqualone;

L Methaqualone.

Unless specifically excepted or unless listed in another schedule, any material, compound, mixture or preparation which contains any quantity of the following substances having a stimulant effecEeffect on the central nervous system, including its salts, isomers and salts of isomers:

D Aminorex (some trade or other names;

2-aminopropiophenone,Cathinone norephedrone),(some andtrade anyor plantother materialnames: from which Cathinone may be derived;

2-amino-1-phenyl-1-propanone, alpha-aminopropiophenone, of 9 2-aminopropiophenone, norephedrone), and any plant material from which Cathinone may be derived;

S Fenethylline;

8 Methcathinone (some other names:

4 alpha-(methylamino)-propiophenone;

R alpha-N-methylaminopropiophenone;

N,N-alpha-trimethylphenethylamine);ames:N,N-dimethylamphetamine (other names:

N,N-alpha-trimethyl-benzeneethanamine, MethylN,N-alpha-trimethylphenethylamine); 2-(4-fluorophenyl)-2-(2-piperidinyl)acetate (other name:

Methyl 2-(4-fluorophenyl)-2-(2-piperidinyl)acetate (other name:

Any substance that contains one or more cannabimimetic agents or that contains their salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation, and any preparation, mixture, or substance containing, or a.mixed or infused with, any detectable amount of one or more cannabimimetic agents.

a.

3-(1-naphthoyl)pyrrole with substitution at the nitrogen atom of the pyrrole ring, whether or not further substituted in the pyrrole ring to any extent, whether or not substituted on the naphthoyl ring to any1-(1-naphthylmethyl)indene with substitution of the 3-position of the indene ring, whether or not further substituted in the indene ring to any extent, whether or not substituted on the naphthyl ring to any extent;

1-(1-naphthylmethyl)indene with substitution of the 3-position of the indene ring, whether or not further substituted in the indene ring to any extent, whether or not substituted on the naphthyl ring to any extent;

3-adamantoylindole with substitution at the nitrogen atom of the indole ring, whether or not further extent;uted on the indole ring to any extent, whether or not substituted on the adamantyl ring to any N-(adamantyl)-indole-3-carboxamide with substitution at the nitrogen atom of the indole ring, of 10 whether or not further substituted on the indole ring to any extent, whether or not substituted on the adamantyl ring to any extent;

N-(adamantyl)-indole-3-carboxamide with substitution at the nitrogen atom of the indole ring, whether or not further substituted on the indole ring to any extent, whether or not substituted on the adamantyl ring to any extent;

of 9 1-pentyl-3-(4-ethyl-1-naphthoyl)indole (other name:

Pravadoline (4-methoxyphenyl)-[2-methyl-1-(2-(4-morpholinyl)ethyl)indol-3-yl]meth(other(4-methoxyphenyl)-[2-methyl-1-(2-(4-morpholinyl)ethyl)indol-3-yl]methanone (other name:

N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)indazole-3-carboxa(otherN-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)indazole-3-carboxamide (other name:

of 10 5-fluoro-ADB, 5-Fluoro-MDMB-PINACA);

Methyl 2-({1-[(4-fluorophenyl)methyl]-1H-indazole-3-carbonyl}amino)-3-methylbuta(other2-({1-[(4-fluorophenyl)methyl]-1H-indazole-3-carbonyl}amino)-3-methylbutanoate E(other names:

N-(adamantan-1-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxam(otherN-(adamantan-1-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide (other names:

FUB-AKB48, N 5F-APINACA);

R N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide (other name:

N-(adamantanyl)-1-(5-chloropentyl) indazole-3-carboxamide (other name:

5-chloro-AKB48);

SDB-005);chloro-AKB48);SDB-005);

O N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)indole-3-carboxamide (other name:

L AB-CHMICA);

L Quinolin-8-yl 1-(4-fluorobenzyl)-1H-indole-3-carboxylate (other name:

E Methyl N-[1-(cyclohexylmethyl)-1H-indole-3-carbonyl]valinate (other name:

N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)indazole-3-carbo(otherN-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)indazole-3-carboxamide (other name:

D 5-fluoro-ADB-PINACA);

4-cyano CUMMethylCUMYL-BUTINACA); 2-[1-(5-fluoropentyl)-1H-indole-3-carboxamido]-3,3-dimethylbutanoate (other names:

Methyl 2-[1-(5-fluoropentyl)-1H-indole-3-carboxamido]-3,3-dimethylbutanoate (other names:

S Methyl 2-[1-4-fluorobutyl)-1H-indazole-3-carboxamido]-3,3-dimethylbutanoate (other name:

8 4-fluoro-MDMB-BUTINACA);

4of 9 1-(5-fluoropentyl)-N-(1-methyl-1-phenylethyl)-1H-indole-3-carboxamide (other name:

5-fluoro R CUMYL-PICA);

MMB-FUBICA,Methyl AMB-FUBICA);rophenyl)methyl]-1H-indole-3-carbonyl}amino)-3-methylbutanoate2-({1-[(4-fluorophenyl)methyl]-1H-indole-3-carbonyl}amino)-3-methylbutanoate (other names:

MMB-FUBICA, AMB-FUBICA);

5-c1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide5-chloro-AB-PINACA); (other names:

1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide (other names:

5-fluoro EDMMethylEDMB-PICA); 2-[1-(4-fluorobutyl)-1H-indole-3-carboxamido]-3,3-dimethylbutanoate (other name:

Methyl 2-[1-(4-fluorobutyl)-1H-indole-3-carboxamido]-3,3-dimethylbutanoate (other name:

Methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3,3-dimethylbutan(other2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoat(other names:

N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indole-3-ace(otherN-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indole-3-aceta(other names:

ADB-FUBIATA, AD-18, FUB-ACADB).

Pursuant to § 30-19.1:4 of the Code of Virginia, the estimated amount of the of 10 necessary appropriation is $0 for periods of imprisonment in state adult correctional facilities and cannot be determined for periods of commitment to the custody of the Department of Juvenile Justice.